why do pbms limit glp-1 medications enforcing quantity limits on GLP1 medication is the physiological equivalent of forcing a physician to double the dose of chemotherapy or BP medication next month for no reason. Allowing for… Building a Cost and Care-Conscious

In addition to achieving significant weight loss, research has shown that GLP-1 drugs can reduce the risk of major cardiovascular events such as heart attack or stroke in people with Type 2 diabetes

Hormonal treatment options include: Combined oral contraceptives : Continuous or cyclic regimens can reduce menstrual flow and suppress endometrial tissue activity Progestins : Available as oral medications, injections (depot medroxyprogesterone acetate), intrauterine devices (levonorgestrel-releasing IUD), or implants GnRH agonists : These medications induce a temporary menopausal state, effectively suppressing endometriosis but requiring add-back hormone therapy to minimize bone loss and vasomotor symptoms GnRH antagonists : FDA-approved oral options include elagolix (Orilissa) and relugolix/estradiol/norethindrone (Myfembree) with specific duration limits based on dosing and bone health considerations Aromatase inhibitors : Sometimes used in refractory cases, though not FDA-approved for this indication Bone mineral density monitoring is recommended for patients on long-term GnRH agonists or antagonists, particularly at higher doses or extended durations

The hormone also decreases the parietal cells secretion of gastrin and stomach acid, proliferates the bones osteoblasts and inhibits osteoclasts, and may be involved in neuro-signaling as evidenced by widespread expression of GIPr in the brain

As of March 2020, nearly 42% of U.S

The catch is, all these trials use different doses (from 300 to 1,500 milligrams per day) and duration (1 to 24 months), so its tough to know exactly what happens when you take berberine